Efficacy of Transctunaous Pulsed Radiofrequency Therapy in Carpal Tunnel Syndrome
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change From Baseline in Pain on the Visual Analog Scale (VAS) at Week 2 and 4
Study Overview
Brief Summary
The aim of this study is to examine the effect of transcutaneous pulsed radiofrequency current in the treatment of carpal tunnel syndrome.
Detailed Description
Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy. Wrist splint is the first-line treatment option for CTS. Pulsed radiofrequency therapy is used in the treatment of chronic pain.
60 carpal tunnel syndrome patients diagnosed with electroneuromyelography will be included in the study. 30 patients will wear wrist splints for 1 month. In the other 30 patients, pulsed radiofrequency current will be given through the wrist median nerve trace. RF current will be applied through transcutaneous pads. It will be applied once a week for a total of 2 sessions, 8 minutes each. Boston carpal tunnel syndrome questionnaire with visual analog scale (VAS) will be applied to all patients before and after the treatment at 1 week and 1 month.
Our aim is to compare the effectiveness of wrist splint and pulsed rf therapy.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Carpal tunnel syndrome detected by electroneuromyography
- •Positive Tinel sign
Exclusion Criteria
- •Thenar muscle atrophy
- •Weakness in the abductor pollicis brevis muscle
Arms & Interventions
Wrist splint group
The group to be treated with a wrist splint
Intervention: Wrist splint (Device)
Transcutaneous pulsed RF group
The group to be treated with transcutaneous pulsed RF
Intervention: Pulsed radiofrequency current (Other)
Outcomes
Primary Outcomes
Change From Baseline in Pain on the Visual Analog Scale (VAS) at Week 2 and 4
Time Frame: Baseline, Week 2 and 4
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "0=no pain" and "10=worst pain.
Boston Carpal Tunnel Syndrome Questionnaire before treatment
Time Frame: Before treatment
The Boston Carpal Tunnel Questionnaire (BCTQ) is a disease-specific measure of self-reported symptom severity and functional status. It is frequently used in the reporting of outcomes from trials into interventions for carpal tunnel syndrome. ıncluding Symptom Severity Scale is 11: no symptoms, 55: worst symptoms and Functional Disability Scale (FDS) no difficulties:8, worst difficulties: 40
Secondary Outcomes
No secondary outcomes reported
Investigators
Damla Yürük
Director, medical doctor
Diskapi Teaching and Research Hospital